- Home
- TEAF vs STIM Comparison
TEAF vs STIM Comparison
Compare TEAF & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEAF
- STIM
- Stock Information
- Founded
- TEAF 2017
- STIM 2003
- Country
- TEAF United States
- STIM United States
- Employees
- TEAF N/A
- STIM N/A
- Industry
- TEAF Trusts Except Educational Religious and Charitable
- STIM Medical/Dental Instruments
- Sector
- TEAF Finance
- STIM Health Care
- Exchange
- TEAF Nasdaq
- STIM Nasdaq
- Market Cap
- TEAF 174.8M
- STIM 192.0M
- IPO Year
- TEAF N/A
- STIM 2018
- Fundamental
- Price
- TEAF $12.07
- STIM $4.13
- Analyst Decision
- TEAF
- STIM Buy
- Analyst Count
- TEAF 0
- STIM 4
- Target Price
- TEAF N/A
- STIM $4.67
- AVG Volume (30 Days)
- TEAF 56.1K
- STIM 2.1M
- Earning Date
- TEAF 01-01-0001
- STIM 03-04-2025
- Dividend Yield
- TEAF 9.20%
- STIM N/A
- EPS Growth
- TEAF N/A
- STIM N/A
- EPS
- TEAF N/A
- STIM N/A
- Revenue
- TEAF N/A
- STIM $72,711,000.00
- Revenue This Year
- TEAF N/A
- STIM $3.23
- Revenue Next Year
- TEAF N/A
- STIM $29.55
- P/E Ratio
- TEAF N/A
- STIM N/A
- Revenue Growth
- TEAF N/A
- STIM 5.03
- 52 Week Low
- TEAF $11.11
- STIM $0.52
- 52 Week High
- TEAF $13.30
- STIM $5.07
- Technical
- Relative Strength Index (RSI)
- TEAF 42.32
- STIM 59.06
- Support Level
- TEAF $12.11
- STIM $2.80
- Resistance Level
- TEAF $12.28
- STIM $5.03
- Average True Range (ATR)
- TEAF 0.10
- STIM 0.49
- MACD
- TEAF -0.00
- STIM 0.04
- Stochastic Oscillator
- TEAF 24.73
- STIM 59.64
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a US-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.